Retension Pharmaceuticals Inc. (RTSN) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-10-16
5:40 pm
Purchase
2026-10-1313GRetension Pharmaceuticals Inc.
RTSN
The B Group, Inc.833,333
10.000%
833,333increase
(New Position)
Filing
History
2026-10-16
1:57 pm
Purchase
2026-10-0913GRetension Pharmaceuticals Inc.
RTSN
PVG ASSET MANAGEMENT CORP1,002,050
8.300%
1,002,050increase
(New Position)
Filing
History
2026-10-15
3:03 pm
Purchase
2026-10-1313GRetension Pharmaceuticals Inc.
RTSN
Laurence W. Lytton617,207
7.400%
617,207increase
(New Position)
Filing
History
2026-10-14
4:05 pm
Purchase
2026-10-1313DRetension Pharmaceuticals Inc.
RTSN
Keller Eric L.598,598
7.070%
598,598increase
(New Position)
Filing
History